Top compounds associated with response to CREBL2


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib GDSC1000 pan-cancer AAC -0.11 0.06
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.068 0.06
mRNA ML312 CTRPv2 pan-cancer AAC 0.14 0.06
mRNA SR1001 CTRPv2 pan-cancer AAC 0.073 0.06
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.06
mRNA oligomycin a CTRPv2 pan-cancer AAC 0.068 0.07
mRNA PHA-793887 GDSC1000 pan-cancer AAC -0.055 0.07
mRNA FK866 CTRPv2 pan-cancer AAC -0.071 0.07
mRNA temsirolimus FIMM pan-cancer AAC 0.32 0.07
mRNA Erlotinib gCSI pan-cancer AAC -0.11 0.07
Download CSV